IBEX INNOVATIONS LTD

Their core work

Ibex Innovations is a UK medical imaging technology company developing advanced X-ray detector systems for clinical and industrial radiology. Their core product is a Quantitative Digital Radiography (QDR) platform that delivers low-dose, high-resolution, high-contrast X-ray imaging — addressing a real clinical gap between standard flat-panel detectors and expensive CT scanning. They progressed through both phases of the EU SME Instrument (now EIC Accelerator), moving from feasibility validation in 2015 to full product development through 2020, indicating a hardware company at an advanced commercialisation stage.

What they specialise in

How they've shifted over time

Ibex Innovations shows a single, focused technology trajectory rather than a shifting research agenda. In 2015 they were at concept-validation stage — MAP-Detector was a Phase 1 feasibility study to establish whether their low-dose, high-contrast X-ray detector was technically and commercially viable. By 2017 they had cleared that gate and moved into full product development with a EUR 1.6M Phase 2 grant, a 32-fold increase in funding. The story is not one of pivot or diversification but of depth — the same core X-ray detector technology maturing from idea to near-market product over five years.

Their Phase 2 project ran through 2020, suggesting a commercial product should either be on the market or in late-stage validation now — making them a potential licensing, integration, or distribution partner rather than a research collaborator.

How they like to work

Ibex Innovations operated as a solo SME in both projects, which is standard for the EU SME Instrument — that funding scheme is designed for single innovative companies, not large consortia. There is no evidence of consortium partnerships in their H2020 record. This means they are a self-contained technology developer rather than a network builder, and any future collaboration would likely position them as a technology provider or sub-contractor rather than a multi-partner coordinator.

No consortium partners are recorded across their two H2020 projects, which reflects the solo-applicant structure of the SME Instrument rather than geographic isolation. Their operational footprint appears concentrated in the UK (Sedgefield, north-east England).

What sets them apart

Ibex Innovations occupies a narrow but defensible niche: hardware-level X-ray detector innovation targeting a performance gap in clinical radiology that software alone cannot close. Unlike most H2020 medical imaging participants — who tend to be universities or large medtech firms — they are a small company that twice won competitive EU peer review for the same core technology, which is a meaningful signal of external validation. For a consortium needing a credible detector-physics or medical-grade imaging hardware partner, they bring IP and prototype-to-product experience that most academic groups cannot offer.

Highlights from their portfolio

• IBEX QDR
  At EUR 1.6M, this was one of the larger SME Instrument Phase 2 grants in medical imaging hardware, and it represents a full product-development cycle — from prototype to market-ready system — funded by EU peer-reviewed competition.
• MAP-Detector
  As the Phase 1 feasibility study that unlocked the Phase 2 grant, MAP-Detector demonstrates that the QDR concept passed independent technical and commercial review — it is the proof point behind the larger project.